Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial-Reference-Cited by-同舟云学术

Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial

Published:2022-06 Issue:6 Volume:7 Page:533-541
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Kateera Fredrick,Shumbusho Fabienne,Manirambona Linda,Kabihizi Jules,Murangwa Anthere,Serumondo Janvier,Makuza Jean Damascene,Nsanzimana Sabin,Muvunyi Claude Mambo,Kabakambira Jean Damascene,Sylvain Habarurema,Camus Gregory,Grant Philip M,Gupta Neil

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Global progress report on HIV, viral hepatitis and sexually transmitted infections 2021. Accountability for the global health sector strategies, 2016–2021: actions for impact,2021

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

3. Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa;Iles;Virology,2014

4. Real-world outcomes of direct-acting antiviral treatment and retreatment in United Kingdom-based patients infected with HCV genotypes/subtypes endemic in Africa;Aranday-Cortes;J Infect Dis,2021

5. Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4;Camus;J Viral Hepat,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23

2. The nucleoside analog 4′-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D polymerase;Antimicrobial Agents and Chemotherapy;2024-04-30

3. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024;Saudi Journal of Gastroenterology;2024-01

4. Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life;Tropical Medicine and Infectious Disease;2023-11-18

5. Hepatitis C;The Lancet;2023-09